H.R. 7667 · 117th Congress
Food and Drug Amendments of 2022
- Stage
- Passed a chamber
- Sponsor
- Anna Eshoo
- Introduced
- 2022-05-06
- Latest action
- 2022-06-09 · Motion to reconsider laid on the table Agreed to without objection.
Subjects
Executive agency funding and structure
Congressional oversight
Health care coverage and access
Performance measurement
Criminal investigation, prosecution, interrogation
Government studies and investigations
Health
User charges and fees
Inflation and prices
Child health
Infectious and parasitic diseases
Medical research
Radiation
Photography and imaging
Licensing and registrations
Health programs administration and funding
Evidence and witnesses
Government employee pay, benefits, personnel management
Minority health
Advisory bodies
Department of Health and Human Services
Health technology, devices, supplies
Emergency medical services and trauma care
Genetics
Employee hiring
Research and development
Small business
Cardiovascular and respiratory health
Musculoskeletal and skin diseases
Government information and archives
Advanced technology and technological innovations
Industrial facilities
Public-private cooperation
Prescription drugs
Blood and blood diseases
Marketing and advertising
Animal protection and human-animal relationships
Public participation and lobbying
Organ and tissue donation and transplantation
Drug safety, medical device, and laboratory regulation
Food and Drug Administration (FDA)
Business records
Computer security and identity theft
Manufacturing
Product development and innovation